VIDEO: ODs should consider ocular surface effects of glaucoma agents
ORLANDO, Fla. – Medications can impact the ocular surface whether or not they contain preservatives, according to Rich Mangan, OD, FAAO; Mitch Ibach, OD, FAAO; and Scott Hauswirth, OD, FAAO, here at the American Academy of Optometry meeting.
Optometrists are in a perfect position to advocate for patients and inform them of alternative technology, they said.
Disclosures: Ibach reports he is a consultant/lecturer for Aerie and Glaukos, a speaker for Alcon and a consultant for Ocular Therapeutix. Hauswirth reports financial relationships with Allergan, BioTissue, Glaukos, Mentholatum, Shire and Sun. Mangan reports no relevant financial disclosures.